Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics

Nat Rev Endocrinol. 2014 Jun;10(6):311. doi: 10.1038/nrendo.2014.57. Epub 2014 Apr 22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenal Cortex Neoplasms / genetics*
  • Adrenal Cortex Neoplasms / metabolism*
  • Adrenocortical Adenoma / genetics*
  • Adrenocortical Adenoma / metabolism*
  • Cushing Syndrome / genetics*
  • Cyclic AMP-Dependent Protein Kinase Catalytic Subunits / genetics*
  • Humans
  • Hydrocortisone / metabolism*

Substances

  • Cyclic AMP-Dependent Protein Kinase Catalytic Subunits
  • Hydrocortisone